Janus kinase inhibitors can be paired with corticosteroids or used as monotherapy in the treatment of alopecia areata.

FDA approves Novo Nordisk's Alhemo for hemophilia A and B without inhibitors, following strong Phase 3 results showing reduced bleeding episodes.